BP vs CVI

BP's Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock trades at a significant premium to its Graham Number ($7.35) and even the growth-based intrinsic value ($18.88), currently priced at $36.53, driven by high forward earnings expectations. While profitability metrics and dividend yield are attractive, elevated valuation multiples, inconsistent earnings surprises, and a dangerously high payout ratio of 315% raise sustainability concerns. Analysts recommend a 'buy' with a target of $38.73, supported by strong insider sentiment, though no insider transactions have occurred recently.

CVI exhibits significant valuation distress, trading at a massive premium to its Graham Number ($6.64) and Intrinsic Value ($1.89). The Piotroski F-Score of 4/9 indicates a stable but mediocre financial health profile, which is overshadowed by a catastrophic YoY EPS decline of 515.4% and negative operating margins (-5.19%). While the dividend yield remains attractive at 4.70%, the underlying profitability is nearly non-existent (0.38% profit margin), and the technical trend is completely bearish (0/100).